相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
ApoB in clinical care: Pro and Con
Allan D. Sniderman et al.
ATHEROSCLEROSIS (2019)
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Insights From the FOURIER Trial
Michelle L. O'Donoghue et al.
CIRCULATION (2019)
Quantifying Importance of Major Risk Factors for Coronary Heart Disease
Michael J. Pencina et al.
CIRCULATION (2019)
Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
Allan D. Sniderman et al.
JOURNAL OF LIPID RESEARCH (2018)
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
Peter Willeit et al.
LANCET (2018)
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias
Allan Sniderman et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk
AD Sniderman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice
EL Willner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
